- Published on:
Brasilia, May 14 (Prensa Latina) The National Health Surveillance Agency (ANVISA) on Thursday authorized clinical trials of Covaxin, an anti-Covid-19 vaccine candidate developed by Indian Pharmaceutical Company Bharat Biotech.
© 2016-2021 Prensa Latina
Latin American News Agency
Radio – Publications – Videos – News by the minute.
All Rigts Reserved.
St. E No 454 , Vedado, Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .
Web Site developed by IT Division Prensa Latina.